Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Averis Ventures is an early-stage investment firm founded to address the funding gap for transformative healthcare companies. Established with a focus on innovative healthcare solutions, the firm specializes in deep life sciences, bio-enabled platforms, and next-generation health systems. Averis Ventures primarily targets companies that often face underfunding due to their technical and regulatory complexities, particularly those emerging from Israel.
The firm operates globally, with a strategic emphasis on the DACH region, which includes Germany, Austria, and Switzerland. This geographic focus allows Averis Ventures to access high-quality investment rounds and opportunities that are not broadly marketed. The firm is committed to supporting companies that are pioneering advancements in healthcare, ensuring they receive the necessary capital to thrive.
Averis Ventures invests in several key sectors, including Deep Life Science & GenBio, which encompasses therapeutics, AI-native biology, diagnostics, and modality-driven platforms. The firm also emphasizes Bio-Enabled Platforms & Infrastructure, focusing on drug discovery tools, bio-manufacturing, process analytics, and data layers. Additionally, Averis Ventures is active in the HealthTech sector, which includes clinical enablement, diagnostics-adjacent software, and regulated care infrastructure.
The firm’s investment strategy is designed to support early-stage companies that are developing innovative healthcare solutions. Averis Ventures seeks to identify startups that are addressing significant challenges in the healthcare industry, particularly those that leverage advanced technologies and scientific breakthroughs. The firm’s commitment to the DACH healthcare ecosystem enhances its ability to connect with promising startups and facilitate impactful investments.
Averis Ventures has a diverse portfolio that includes companies across various sectors of healthcare. Notable investments include:
This portfolio reflects Averis Ventures' commitment to investing in companies that are at the forefront of healthcare innovation, particularly those that leverage advanced technologies to improve patient outcomes.
Fabio Kauermann - Partner at Averis Ventures, Fabio has extensive experience in venture capital and healthcare investments. He has previously worked with leading firms in the biotech sector and has a strong background in identifying promising startups.
Shani Amram - Partner, Shani brings a wealth of knowledge in healthcare technology and investment strategies. She has a proven track record of supporting early-stage companies in the health sector.
Dr. Natanja Slager - Strategic Advisor & IC Member, Dr. Slager has a deep understanding of the life sciences industry and provides critical insights into investment decisions. Her expertise is instrumental in guiding the firm’s investment strategy.
Founders can pitch to Averis Ventures through the online application form provided on their website. It is important to include a comprehensive overview of the business, including the team, market opportunity, and financial projections. The firm prefers detailed decks that clearly outline the startup's vision and strategy.
In recent months, Averis Ventures has made several notable investments in the healthcare sector, focusing on companies that are leveraging AI and biotechnology to drive innovation. The firm has also announced plans to expand its portfolio in the DACH region, seeking to identify high-potential startups that align with its investment thesis.
Additionally, Averis Ventures has participated in industry conferences and events to enhance its visibility and connect with emerging companies in the healthcare space. The firm continues to build its reputation as a key player in early-stage healthcare investments.
What are Averis Ventures' investment criteria?
Averis Ventures focuses on early-stage companies in the healthcare sector, particularly those in biotech, healthcare, and AI. The firm looks for innovative solutions that address significant challenges in the healthcare industry.
How can I apply or pitch to Averis Ventures?
Founders can apply through the online application form available at this link. It is recommended to provide a detailed overview of the business model, market opportunity, and team background.
What makes Averis Ventures different from other investors?
Averis Ventures specializes in transformative healthcare companies and has a unique focus on addressing the funding gap for innovative solutions, particularly those emerging from Israel. The firm’s expertise in deep life sciences and bio-enabled platforms sets it apart.
What is the geographic scope of Averis Ventures?
The firm operates globally, with a particular emphasis on the DACH region, which includes Germany, Austria, and Switzerland. This focus allows Averis Ventures to tap into high-quality investment opportunities in these markets.
What is the typical check size for investments?
Averis Ventures typically invests at the pre-seed, seed, and Series A stages, with check sizes varying based on the specific needs of the startup and the potential for growth.
What kind of post-investment support does Averis Ventures provide?
The firm actively engages with portfolio companies, offering mentorship, strategic guidance, and access to its network of industry contacts to help drive growth and success.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.